These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877 [TBL] [Abstract][Full Text] [Related]
4. Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Tang MS; Case JB; Franks CE; Chen RE; Anderson NW; Henderson JP; Diamond MS; Gronowski AM; Farnsworth CW Clin Chem; 2020 Dec; 66(12):1538-1547. PubMed ID: 32894750 [TBL] [Abstract][Full Text] [Related]
5. Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds. Larkey NE; Ewaisha R; Lasho MA; Roforth MM; Granger D; Jerde CR; Wu L; Gorsh A; Klassen SA; Senefeld JW; Joyner MJ; Baumann NA; Theel ES; Mills JR Microbiol Spectr; 2022 Aug; 10(4):e0115422. PubMed ID: 35862939 [TBL] [Abstract][Full Text] [Related]
6. Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG. Salazar E; Christensen PA; Graviss EA; Nguyen DT; Castillo B; Chen J; Lopez BV; Eagar TN; Yi X; Zhao P; Rogers J; Shehabeldin A; Joseph D; Masud F; Leveque C; Olsen RJ; Bernard DW; Gollihar J; Musser JM Am J Pathol; 2021 Jan; 191(1):90-107. PubMed ID: 33157066 [TBL] [Abstract][Full Text] [Related]
7. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729 [TBL] [Abstract][Full Text] [Related]
8. Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay. Goodhue Meyer E; Simmons G; Grebe E; Gannett M; Franz S; Darst O; Di Germanio C; Stone M; Contestable P; Prichard A; Reik R; Vassallo R; Young P; Busch MP; Williamson P; Dumont LJ Transfusion; 2021 Apr; 61(4):1160-1170. PubMed ID: 33554362 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
10. Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay. Janaka SK; Clark NM; Evans DT; Mou H; Farzan M; Connor JP PLoS One; 2021; 16(7):e0253551. PubMed ID: 34310603 [TBL] [Abstract][Full Text] [Related]
12. Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction. Lamikanra A; Nguyen D; Simmonds P; Williams S; Bentley EM; Rowe C; Otter AD; Brooks T; Gilmour K; Mai A; Dadhra J; Csatari M; Ziyenge S; Oliveira M; Ploeg R; Tsang P; Zambon M; Gopal R; Xiao JH; Townsend A; Roberts D; Harvala H Transfusion; 2021 Oct; 61(10):2837-2843. PubMed ID: 34342366 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714 [TBL] [Abstract][Full Text] [Related]
14. Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Lin YJ; Evans DH; Robbins NF; Orjuela G; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Tuite A; Yi QL; O'Brien SF; Drews SJ Microbiol Spectr; 2022 Oct; 10(5):e0281122. PubMed ID: 36125288 [TBL] [Abstract][Full Text] [Related]
15. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations. Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595 [TBL] [Abstract][Full Text] [Related]
16. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease. Gniadek TJ; Thiede JM; Matchett WE; Gress AR; Pape KA; Fiege JK; Jenkins MK; Menachery VD; Langlois RA; Bold TD Transfusion; 2021 Jan; 61(1):17-23. PubMed ID: 32935872 [TBL] [Abstract][Full Text] [Related]
18. Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality. Hähnel V; Peterhoff D; Bäuerlein V; Brosig AM; Pamler I; Johnson C; Bica A; Totir M; Ossner T; Stemmer B; Toelge M; Schütz A; Niller HH; Schmidt B; Wagner R; Gessner A; Burkhard R; Offner R PLoS One; 2020; 15(12):e0243967. PubMed ID: 33351831 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance. Di Germanio C; Simmons G; Kelly K; Martinelli R; Darst O; Azimpouran M; Stone M; Hazegh K; Grebe E; Zhang S; Ma P; Orzechowski M; Gomez JE; Livny J; Hung DT; Vassallo R; Busch MP; Dumont LJ Transfusion; 2021 Sep; 61(9):2677-2687. PubMed ID: 34121205 [TBL] [Abstract][Full Text] [Related]